10:16 AM EST - Med BioGene Inc. : reported its financial results for 2009. The company incurred losses in 2009 of $2.135 million U.S., or $0.04 U.S. per share, compared to a loss of $2.140 million U.S., or $0.06 U.S. per share in last year. Med BioGene did not generate any revenue during 2009 or 2008. Med BioGene Inc.
shares V.MBI are trading even at $0.17.
